Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Doxapram as an Additive to Propofol Sedation in Sedation for Endoscopic Retrograde Cholangiopancreatography

NCT02171910 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.

NCT NCT02171910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02171910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Doxapram as an Additive to Propofol Sedation in Sedation for Endoscopic Retrograde Cholangiopancreatography
Lead sponsor
Helsinki University Central Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2016
Completion date
December 31, 2016
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxia, sedation